Pfizer logo

PFIZER - Pfizer Share Price

₹5081.95 305.9  6.4%

Last Trade - 13/04/21

Mid Cap
Market Cap £2.26bn
Enterprise Value £2.17bn
Revenue £214.1m
Position in Universe 167th / 3106
Unlock PFIZER Revenue
Relative Strength (%)
1m +13.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -13.9%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
18,533 20,938 20,419 19,802 20,815 21,517 22,541 24,435 +3.0%
-60.2 +122.6 -15.9 +43.3 +13.9 +18.4 +6.68 +7.47
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, PfizerLimited revenues increased 3% to RS17.04B. Net incomedecreased 2% to RS3.97B. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income was offset by OtherIncome decrease of 45% to RS439.2M (income), Depreciationand amortization expense increase of 10% to RS821M(expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for PFIZER
Graphical History


PFIZER Revenue Unlock PFIZER Revenue

Net Income

PFIZER Net Income Unlock PFIZER Revenue

Normalised EPS

PFIZER Normalised EPS Unlock PFIZER Revenue

PE Ratio Range

PFIZER PE Ratio Range Unlock PFIZER Revenue

Dividend Yield Range

PFIZER Dividend Yield Range Unlock PFIZER Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PFIZER EPS Forecasts Unlock PFIZER Revenue
Profile Summary

Pfizer Limited is an India-based pharmaceutical company. The Company has a portfolio of approximately 140 products across over 15 therapeutic areas. The Company is engaged in manufacturing, marketing, trading and exporting pharmaceutical products. The Company offers a range of products for Anti-Allergic, Anti-Diabetic, Antihistamine, Anti-Infectives, Cardiovascular, Dermatology, Erectile Dysfunction, gastrointestinal (GI), Multivitamins, Pain/Inflammation+GI, Respiratory, Urology and Vitamin/Minerals, among others. Its products include LC-OD Plus, Bidiab, Voglibose, Histizer, Isokin, Jetex Suspension, Nebasulf Ointment, Trulimax, Combantrin A, Newsta, Selsun, Agarol, Oxileptin, Ponstan, Daxid, Tricorex, Citrosoda and Cognisules, among others. The Company has its own manufacturing facility at Thane and Goa. The Company has various independent contract/third party manufacturers based across the country. The Company sells its products through independent distributors primarily in India.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated November 21, 1950
Public Since December 9, 1994
No. of Shareholders: 85,972
No. of Employees: 2,489
Sector Healthcare
Industry Pharmaceuticals
Exchange National Stock Exchange of India
Shares in Issue 45,750,000
Free Float (0.0%)
Eligible for
PFIZER Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for PFIZER
Upcoming Events for PFIZER
Frequently Asked Questions for Pfizer
What is the Pfizer share price?

As of 13/04/21, shares in Pfizer are trading at ₹5081.95, giving the company a market capitalisation of £2.26bn. This share price information is delayed by 15 minutes.

How has the Pfizer share price performed this year?

Shares in Pfizer are currently trading at ₹5081.95 and the price has moved by 22.1% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Pfizer price has moved by -23.21% over the past year.

What are the analyst and broker recommendations for Pfizer?

Of the analysts with advisory recommendations for Pfizer, there are there are currently 3 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Pfizer is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Pfizer next release its financial results?

Pfizer is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Pfizer dividend yield?

The Pfizer dividend yield is 0.2% based on the trailing twelve month period.

Does Pfizer pay a dividend?

Last year, Pfizer paid a total dividend of 10, and it currently has a trailing dividend yield of 0.2%. Looking ahead, Pfizer has not announced an ex-dividend date yet.

When does Pfizer next pay dividends?

Pfizer has yet to annouce their ex-dividend date. The historic dividend yield on Pfizer shares is currently 0.2%.

How do I buy Pfizer shares?

To buy shares in Pfizer you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Pfizer?

Shares in Pfizer are currently trading at ₹5081.95, giving the company a market capitalisation of £2.26bn.

Where are Pfizer shares listed? Where are Pfizer shares listed?

Here are the trading details for Pfizer:

Country of listing: India
Exchange: NSI
Ticker Symbol: PFIZER
What kind of share is Pfizer?

Based on an overall assessment of its quality, value and momentum, Pfizer is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Pfizer share price forecast 2021?

Shares in Pfizer are currently priced at ₹5081.95. At that level they are trading at 4.46% discount to the analyst consensus target price of 0.00.

Analysts covering Pfizer currently have a consensus Earnings Per Share (EPS) forecast of 113.225 for the next financial year.

How can I tell whether the Pfizer share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pfizer. Over the past six months, the relative strength of its shares against the market has been -17.19%. At the current price of ₹5081.95, shares in Pfizer are trading at 6.69% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Pfizer PE Ratio?

The Pfizer PE ratio based on its reported earnings over the past 12 months is 46.94. The shares are currently trading at ₹5081.95.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Pfizer?

Pfizer's management team is headed by:

Rajendra Shah - NEC
Pradip Shah - IND
S. Sridhar - MDR
Prajeet Nair - CCO
Uday Khanna - NID
Aijaz Tobaccowalla - EDR
Sunil Lalbhai - IND
Milind Patil - FID
Who are the major shareholders of Pfizer?

Here are the top five shareholders of Pfizer based on the size of their shareholding:

Pfizer Inc Corporation
Percentage owned: 63.92% (29.2m shares)
Aditya Birla Sun Life AMC Limited Investment Advisor
Percentage owned: 6.81% (3.11m shares)
Aditya Birla Sun Life Tax Relief 96 Mutual Fund
Percentage owned: 4.1% (1.88m shares)
LIC Mutual Fund Asset Management Company Ltd. Investment Advisor
Percentage owned: 3.31% (1.51m shares)
Lalbhai Group Corporation
Percentage owned: 2.1% (959k shares)
Similar to PFIZER
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.